皮膚傷の治療におけるサクラルファートの局所的使用:獣医の視点での説明レビュー
Lucrezia Accorroni1, Fabrizio Dini1, Nicola Pilati1
1School of Biosciences and Veterinary Medicine, University of Camerino, Via Circonvallazione 93/95, 62024 Matelica, MC, Italy.
Veterinary sciences
|August 28, 2025
まとめ
局所用スクラルファートは,成長因子を保護し,組織修復を促進することによって,獣医の創傷治癒の可能性を示しています. 動物,特に馬と猫での有効性を確認するには,さらなる臨床試験が必要です.
科学分野:
- 獣医学
- 傷 の 治し方 の 生物学
- 薬理学について
背景:
- ガストロプロテクティブ剤であるスカルファートは,ヒトの皮膚病変に対して局所的な効果を示しています.
- 成長因子を保護し 血管新生を促進し 酸化ストレスを軽減します
- 局所用スクラルファートに関する獣医学文献は限られており,ほとんどのデータは動物モデルから得られています.
研究 の 目的:
- 人間と獣医の創傷治癒における局所用スカルファートのメカニズムと治療効果をレビューする.
- サクラファートに関する獣医専用の臨床試験の必要性を強調する.
- 動物の福祉と回復時間を改善するスクラルファートの可能性を調査する.
主な方法:
- サクラファートの効果に関する既存の文献の記述レビュー.
- 人間と動物の研究から得られた証拠を統合する.
- 獣医の応用における知識のギャップを特定する
主要な成果:
- サクラルファートは,強化されたコラーゲン合成,新血管化,および線維細胞の活動を通じて傷の治癒を促進します.
- バクテリオスタティック/殺菌効果を示し,酸化ストレスを軽減します.
- 初期データによると,サクラフェートは動物モデルで治癒を加速させる.
結論:
- 局所用スクラルファートは,獣医の創傷管理のための有望で費用対効果の高い薬剤です.
- 獣医の創傷治癒における種特有の課題は,スカルファートから利益を得ることができます.
- 臨床的有効性と安全性を検証するには,制御された獣医試験が不可欠です.
関連する概念動画
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
684
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
684
Peptic Ulcer Disease IV: Management
145
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
145
Peptic Ulcer Disease V: Surgical Management and Nursing Care
406
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
406
Phases of Wound Repair
6.3K
Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
6.3K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
595
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
595
Inflammatory Bowel Disease V: Surgical Management
206
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
206


